Neoadjuvant chemotherapy induces phenotypic mast cell changes in high grade serous ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Neoadjuvant chemotherapy induces phenotypic mast cell changes in high grade serous ovarian cancer ; volume:17 ; number:1 ; day:28 ; month:9 ; year:2024 ; pages:1-12 ; date:12.2024
Journal of ovarian research ; 17, Heft 1 (28.9.2024), 1-12, 12.2024
- Creator
-
McAdams, Julia
Ebott, Jasmine
Jansen, Corinne
Kim, Chloe
Maiz, Daniela
Ou, Joyce
Hanley, Linda C.
Cruz, Payton De La
James, Nicole E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-024-01516-y
- URN
-
urn:nbn:de:101:1-2412142110057.803541995834
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- McAdams, Julia
- Ebott, Jasmine
- Jansen, Corinne
- Kim, Chloe
- Maiz, Daniela
- Ou, Joyce
- Hanley, Linda C.
- Cruz, Payton De La
- James, Nicole E.
- SpringerLink (Online service)
Other Objects (12)
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer
Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma
New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Neoadjuvant Chemotherapy for Advanced Ovarian Cancer
Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer
Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma
ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Prediction of neoadjuvant chemotherapy response in breast cancer
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer
Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma
New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Neoadjuvant Chemotherapy for Advanced Ovarian Cancer
Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer
Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma
ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Prediction of neoadjuvant chemotherapy response in breast cancer
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer
Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma
New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Neoadjuvant Chemotherapy for Advanced Ovarian Cancer
Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer
Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma
ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer